The medical reform office said: cut another 70 billion yuan of drug costs this year! Equipment price negotiation

Source: Cyprian blue released new signals again on the national drug price reform on March 13, 2017 Yesterday (March 11) morning, the press conference was held at the press center of the fifth session of the 12th National People's Congress Li Bin, director of the national health and Family Planning Commission, Wang Peian, deputy director, and Wang Hesheng, deputy director and director of the State Council's medical reform office, answered questions from reporters about the current issues concerning medical reform that are generally concerned by the market Including that all varieties of national drug price negotiation in 2016 have been included in the medical insurance, and a new round of drug price negotiation is about to start; in 2017, all public hospitals cancelled drug markup, which will save 60 billion to 70 billion yuan in drug costs and other important information was released yesterday ▍ cut another 70 billion yuan! "According to incomplete statistics this year, it is estimated that 60-70 billion yuan will be saved for the masses in drug costs again." Wang Hesheng, deputy director of the national health and Family Planning Commission and director of the medical reform office, told a press conference at the press center of the National People's Congress yesterday According to the requirements of the previous 2017 government work report, this year we will comprehensively push forward the comprehensive reform of public hospitals, and completely cancel the drug mark up, which means that China's public medical institutions will completely say goodbye to the era of "medicine for medicine" However, since the 1950s, it is not easy to eliminate the drug addition and the interest path dependence formed due to historical reasons Because of this, the new round of deepening medical reform launched in 2009 has not yet made substantive changes on this issue In response, Wang Hesheng, deputy director of the national health and Family Planning Commission and director of the medical reform office, also admitted: "it should be said that it is difficult to achieve such a goal and change the previous operation mechanism Because it involves not only the profound adjustment of interests, but also the reform of system and mechanism, as well as the joint reform of medical treatment, medical insurance and medicine Therefore, we say that the elimination of the mechanism of "medicine for medical treatment" is the top priority of our deepening medical reform, and also the most difficult hard bone we can chew this year " He further said that at this stage, "medicine for medical treatment" has gradually evolved into a profit-making mechanism Problems such as large prescriptions, large infusion and abuse of antibiotics have become increasingly serious, pushing up medical costs and weakening the public welfare of public medical institutions, which urgently need to be solved through reform Public information shows that, in fact, since the new round of medical reform in 2009, the cancellation of "drug mark up" has been regarded as a breakthrough to break the mechanism of "medical supplement with drugs" -- in 2011, drug mark up was cancelled in all grass-roots public medical institutions run by the government; in 2015, drug mark up was cancelled in all county-level public hospitals; in 2016, 200 pilot cities for comprehensive reform of public hospitals were cancelled A drug mark up was made According to the official data, with the cancellation of drug mark up and the decrease of drug cost year by year, the proportion of drugs in public hospitals has decreased from 46% in 2009 to 40% at present Since 2016, relevant policies supporting this goal have been issued intensively: carry out the whole process reform of drug production, circulation and use, squeeze the virtual high water content of drug price, start the reform of medical insurance payment mode, stimulate the endogenous power of rational drug use and cost control of hospitals and medical personnel, and make room for reducing drug price, establishing medical consortia and standardizing medical service behavior In order to adjust the price of medical services, we began to land in Sanming, Fujian and Tianchang, Anhui On the evening of February 14, a single news report titled "Anhui Tianchang: establishing grass-roots medical community" in the CCTV news broadcast column reported the experience and practice of establishing medical community and promoting hierarchical diagnosis and treatment in the pilot work of promoting comprehensive reform of county-level public hospitals in Tianchang City, Anhui Province, which made Anhui Tianchang become another star area of medical reform after Sanming in Fujian Province "We have estimated that for patients with the same disease type and severity, the cost of medical treatment in Nanjing is about 4 times of that in days For example, for appendicitis surgery, the cost of Tianchang hospital is 4000 yuan, and the threshold fee is 600 yuan; for Nanjing, it is 15000 yuan, and the threshold fee is 2500 yuan After reimbursement of 70% and 40% of the medical insurance fund, the self payment of patients is 1620 yuan and 10000 yuan respectively " Tianchang New Rural Cooperative Management Center Director Zhu Zongzhi introduced ▍ the scope of drug price negotiation has been expanded, and the equipment has to be discussed At yesterday's meeting, the latest progress of drug price negotiation, which is concerned by the public, innovative drugs and multinational pharmaceutical enterprises, has also been made public Li Bin, director of the national health and Family Planning Commission, said at the meeting yesterday that national negotiations are a form of effective drug price reduction, but not the only one "After the trial last year (2016), it has achieved good results So this year, the human resources and social security department and the health and family planning department, according to the clinical needs, selected a number of varieties that may carry out price negotiations At present, the work has not been finalized Once confirmed, the information will be made public We are also open to enterprises that produce such drugs " Li Bin revealed She stressed several principles of the second round of drug price negotiation: first, it is urgently needed in clinical practice Second, practice has proved that the curative effect is relatively good Third, we should choose the drugs with high prices and heavy burdens on the masses In May 2016, the results of the first batch of national drug price negotiations were announced The prices of tenofovir ester, a first-line treatment drug for chronic hepatitis B, exetane and gefitinib, three drugs targeted for non-small cell lung cancer, all fell by more than 50% Seven departments, including the national health and family planning Commission, the national development and Reform Commission and the Ministry of human resources and social security, jointly issued a notice to require all regions to do a good job in centralized procurement of national negotiated drugs However, due to the actual level of local finance and other issues, according to the statistics of the national health and Family Planning Commission, as of the middle of July of that year, only 14 provinces in the country had issued national negotiated drug implementation documents, and 21 provinces included negotiated drugs in the scope of all kinds of medical insurance compliance costs - nearly one third of the provinces did not connect the price reduced drugs with medical insurance, but the vast majority of the two-thirds of the provinces that have already connected Most provinces also choose only one or two drugs for reimbursement In response, Li Bin yesterday announced the latest situation of medical insurance negotiation drugs entering into medical insurance nationwide "Here, we can also tell you the good news The drugs that were negotiated by the state last year have all been included in the coverage of medical insurance reimbursement this year The masses can make reimbursement according to the proportion." Li Bin further revealed At the same time, she said that while reducing the circulation cost through the two vote system, the next step will be to encourage cross regional joint procurement, especially for some patent drugs, exclusive varieties, including some high-value consumables, to encourage joint procurement, volume procurement and reduce prices This year, a variety of measures will be adopted, including national price negotiations on some high-value medical consumables pilot projects, to reduce the false high prices.